CE15 - Immunologie, Infectiologie et Inflammation 2021

Innate immune mechanisms underlying the persistence of Zika virus in the human testis – INNATESTIS

Submission summary

Persistent viral infections of the male genital tract have far-reaching implication for human health, including diseases spreading. The emerging arbovirus Zika (ZIKV)is sexually transmitted by cured men and we demonstrated it persistently infects the human testis. We postulate that persistent testis infection is enabled by a specific innate immune response designed to ensure homeostasis in this immune privileged organ. In this project, we will use our unique ex vivo model of human testis together with cutting-edge transcriptomic techniques to decipher the cellular and molecular bases of ZIKV persistence (WP1) and perform in-depth mechanistic studies of new host persistence factors (WP2). Last but not least, we will develop a predictive experimental model of the persistence of emerging viruses in the testis and test antiviral approaches (WP3). For this, we have assembled a highly qualified consortium including experts in virology, innate immunity, molecular immunology, testis physiology and single cell genomics.

Project coordination

Nathalie Dejucq-Rainsford (Institut de recherche en santé, environnement et travail)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

IRSET Institut de recherche en santé, environnement et travail
IRSET Institut de recherche en santé, environnement et travail
IP-Signalisation antivirale Unité de Signalisation antivirale
IP-Signalisation des cytokines Unité de Signalisation des cytokines
University of Lausanne / Institute of Microbiology

Help of the ANR 449,030 euros
Beginning and duration of the scientific project: September 2021 - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter